Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SABS | RNXT | CLDI | ||
| Company | Sab Biotherapeutics Inc | Renovorx Inc | Calidi Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 3.22 | 1.3000 | 2.12 | ||
| High | 3.22 | 1.5800 | 2.20 | ||
| Low | 3.00 | 1.1841 | 1.96 | ||
| Last | 3.13 | 1.2900 | 2.14 | ||
| Change | +0.06 | +0.0799 | -0.01 | ||
| % Change | +1.95% | +6.60% | -0.47% | ||
| Volume | 28,400 | 263,000 | 1,488,800 | ||
| 20-Day Average Volume | 83,580 | 56,950 | 3,429,360 | ||
| Previous Close | 3.07 | 1.2101 | 2.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.37 | 1.0876 | 1.80 | ||
| 20-Day Raw Stochastic | 25.66% | 57.35% | 40.07% | ||
| 20-Day Relative Strength | 50.05% | 67.49% | 57.15% | ||
| Weighted Alpha | -64.13 | -5.54 | -60.08 | ||
| Today's Opinion | 8% Buy | 8% Buy | 8% Buy | ||
| Previous Opinion | 8% Buy | 8% Buy | 8% Buy | ||
| Last Month's Opinion | 80% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.97% since 11/15/24 | +18.35% since 11/15/24 | -2.28% since 11/15/24 | ||
| Low | 2.95 on 11/21/24 | 1.0400 on 11/19/24 | 1.96 on 11/22/24 | ||
| High | 3.56 on 11/18/24 | 1.5800 on 11/22/24 | 2.51 on 11/19/24 | ||
| 1-Month | |||||
| %Chg | +9.82% since 10/22/24 | +29.00% since 10/22/24 | +89.38% since 10/22/24 | ||
| Low | 2.60 on 10/25/24 | 0.7736 on 10/24/24 | 0.73 on 10/25/24 | ||
| High | 4.37 on 11/04/24 | 1.5800 on 11/22/24 | 3.89 on 11/13/24 | ||
| 3-Month | |||||
| %Chg | +15.93% since 08/22/24 | +32.98% since 08/22/24 | +48.61% since 08/22/24 | ||
| Low | 2.36 on 10/15/24 | 0.7736 on 10/24/24 | 0.73 on 10/25/24 | ||
| High | 4.37 on 11/04/24 | 1.5800 on 11/22/24 | 3.89 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | +10.21% since 05/22/24 | -7.86% since 05/22/24 | -5.52% since 05/22/24 | ||
| Low | 2.16 on 08/14/24 | 0.7736 on 10/24/24 | 0.73 on 10/25/24 | ||
| High | 4.37 on 11/04/24 | 1.5800 on 11/22/24 | 4.90 on 05/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 28,334 | 29,044 | 28,118 | ||
| Shares Outstanding, K | 9,229 | 24,001 | 13,078 | ||
| Annual Sales | 2,240,000 | 0 | 0 | ||
| Annual Net Income | -42,190,000 | -10,230,000 | -29,220,000 | ||
| Last Quarter Sales | 260,000 | 0 | 0 | ||
| Last Quarter Net Income | -7,340,000 | -2,470,000 | -5,070,000 | ||
| 60-Month Beta | 0.63 | 0.99 | 0.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.12 on 11/06/24 | -0.10 on 11/13/24 | -0.65 on 11/12/24 | ||
| Latest Earnings Date | 11/11/24 | 11/11/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||